Ube, Japan

Osami Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: Ube Industries, Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osami Sakamoto. Retrieved from https://idiyas.com/inventor/osami-sakamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osami Sakamoto: Innovator in Pharmaceutical Chemistry

Introduction

Osami Sakamoto is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on 5-fluorouracil derivatives. His innovative approach has led to advancements in cancer treatment options.

Latest Patents

Sakamoto holds a patent for a 5-fluorouracil derivative, specifically for the compound represented by the formula (1). This compound includes various groups that enhance its efficacy in medical applications. The patent details the structure and potential uses of the derivative, which is crucial for developing effective cancer therapies. He has 1 patent to his name.

Career Highlights

Sakamoto is associated with Ube Industries, Inc., where he has been instrumental in research and development. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry. His dedication to innovation in drug development is commendable.

Collaborations

Throughout his career, Sakamoto has collaborated with esteemed colleagues such as Akihide Koda and Jun'ichiro Kita. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Osami Sakamoto's contributions to pharmaceutical chemistry, particularly through his patent on 5-fluorouracil derivatives, highlight his role as an innovator in the field. His work continues to influence cancer treatment and showcases the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…